CLEC2D and acute lymphoblastic leukemia: The expression of LLT1 on monocytes decreased after induction chemotherapy (2BD) in very high-risk (45.23%), high-risk (60.8%), and standard risk/low-risk (47.29%) ALL subjects but was higher than the healthy (44.9%) subjects (Figure 4F).